ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2022

Clinical review considerations of class I PI3K inhibitors in hematolymphatic malignancies by Center for Drug Evaluation.

Limin Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.